GYRO Share Price

Open 20.75 Change Price %
High 20.92 1 Day 0.04 0.19
Low 20.75 1 Week 0.24 1.17
Close 20.79 1 Month 0.26 1.27
Volume 5069 1 Year -10.54 -33.64
52 Week High 32.55
52 Week Low 0.00
GYRO Important Levels
Resistance 2 20.95
Resistance 1 20.88
Pivot 20.82
Support 1 20.70
Support 2 20.63
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
DCTH 0.02 0.00%
SUSQ 14.20 -0.77%
SIRI 5.29 3.32%
ACAS 17.99 0.39%
More..
NASDAQ USA Top Gainers Stocks
SPIR 0.02 100.00%
LOCM 0.09 50.00%
NIHD 0.74 39.62%
NIHD 0.74 39.62%
WRES 0.09 28.57%
CGEI 0.28 27.27%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
AEZS 1.18 22.92%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
CLSN 0.23 -93.11%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

Gyrodyne Company of America, Inc. (NASDAQ: GYRO)

GYRO Technical Analysis 2
As on 26th May 2017 GYRO Share Price closed @ 20.79 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 21.05 & Buy for SHORT-TERM with Stoploss of 20.40 we also expect STOCK to react on Following IMPORTANT LEVELS.
GYRO Target for May
1st Target up-side 32.25
2nd Target up-side 40.46
3rd Target up-side 48.67
1st Target down-side 8.81
2nd Target down-side 0.6
3rd Target down-side -7.61
GYRO Other Details
Segment EQ
Market Capital 159124768.00
Sector Financial
Industry REIT - Office
Offical website http://www.gyrodyne.com
GYRO Address
GYRO
1 Flowerfield
Suite 24
St James, NY 11780
United States
Phone: 631-584-5400
Fax: 631-584-7075
GYRO Latest News
Interactive Technical Analysis Chart Gyrodyne Company of America, Inc. ( GYRO NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Gyrodyne Company of America, Inc.
GYRO Business Profile
Gyrodyne Company of America, Inc. (Gyrodyne) is a self-managed and self-administered real estate investment trust (REIT). The Company�s primary business is the investment in and the acquisition, ownership and management of a geographically diverse portfolio of medical office and industrial properties and development of industrial and residential properties. As of December 31, 2011, it had 100% ownership in three medical office parks comprising approximately 131,000 rentable square feet and a multitenant industrial park comprising 128,141 rentable square feet. In addition, the Company has approximately 68 acres of property in St. James, New York and an approximate 9.32% limited partnership interest in a limited partnership which owns an undeveloped Florida property, the Grove. As of December 31, 2011, Gyrodyne owns and manages 139,000 square feet of medical office space, all of which is occupied, with properties in the suburbs of New York City and Washington, DC.